<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 16 Aug 2022 09:03:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg</title>
   <link>http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Akorn+Announces+FDA-approved+Generic+Cetrorelix+Acetate+for+Injection+0.25+mg/20472581.html</guid>
   <pubDate>Tue, 16 Aug 2022 09:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10370279</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00389460</category>
   	  </item>
  <item>
   <title>Form  8-K        AKORN INC                 For: Jun 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+Jun+17/17021718.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+Jun+17/17021718.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+Jun+17/17021718.html</guid>
   <pubDate>Thu, 18 Jun 2020 09:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Form  25-NSE     AKORN INC                              Filed by: The Nasdaq Stock Market LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++AKORN+INC++++++++++++++++++++++++++++++Filed+by%3A+The+Nasdaq+Stock+Market+LLC/16986758.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++AKORN+INC++++++++++++++++++++++++++++++Filed+by%3A+The+Nasdaq+Stock+Market+LLC/16986758.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++AKORN+INC++++++++++++++++++++++++++++++Filed+by%3A+The+Nasdaq+Stock+Market+LLC/16986758.html</guid>
   <pubDate>Tue, 09 Jun 2020 10:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Form  8-K        AKORN INC                 For: May 20</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+May+20/16929907.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+May+20/16929907.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+May+20/16929907.html</guid>
   <pubDate>Tue, 26 May 2020 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Form  8-K        AKORN INC                 For: May 20</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+May+20/16919134.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+May+20/16919134.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AKORN+INC+++++++++++++++++For%3A+May+20/16919134.html</guid>
   <pubDate>Thu, 21 May 2020 17:23:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Akorn (AKRX) files voluntary protection under Chapter 11 </title>
   <link>http://www.streetinsider.com/Corporate+News/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html</guid>
   <pubDate>Thu, 21 May 2020 06:12:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Akorn (AKRX) files voluntary protection under Chapter 11 </title>
   <link>http://www.streetinsider.com/Management+Comments/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html</guid>
   <pubDate>Thu, 21 May 2020 06:12:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Akorn (AKRX) files voluntary protection under Chapter 11 </title>
   <link>http://www.streetinsider.com/Hot+Corp.+News/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Corp.+News/Akorn+%28AKRX%29+files+voluntary+protection+under+Chapter+11+/16914705.html</guid>
   <pubDate>Thu, 21 May 2020 06:12:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success</title>
   <link>http://www.streetinsider.com/Press+Releases/Akorn+to+Use+Voluntary+Chapter+11+Process+to+Position+Business+for+Long-Term+Success/16914064.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Akorn+to+Use+Voluntary+Chapter+11+Process+to+Position+Business+for+Long-Term+Success/16914064.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Akorn+to+Use+Voluntary+Chapter+11+Process+to+Position+Business+for+Long-Term+Success/16914064.html</guid>
   <pubDate>Wed, 20 May 2020 23:52:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success</title>
   <link>http://www.streetinsider.com/PRNewswire/Akorn+to+Use+Voluntary+Chapter+11+Process+to+Position+Business+for+Long-Term+Success/16914064.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Akorn+to+Use+Voluntary+Chapter+11+Process+to+Position+Business+for+Long-Term+Success/16914064.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Akorn+to+Use+Voluntary+Chapter+11+Process+to+Position+Business+for+Long-Term+Success/16914064.html</guid>
   <pubDate>Wed, 20 May 2020 23:52:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Form  4          AKORN INC                 For: May 09  Filed by: Portwood Duane A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AKORN+INC+++++++++++++++++For%3A+May+09++Filed+by%3A+Portwood+Duane+A/16874326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AKORN+INC+++++++++++++++++For%3A+May+09++Filed+by%3A+Portwood+Duane+A/16874326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AKORN+INC+++++++++++++++++For%3A+May+09++Filed+by%3A+Portwood+Duane+A/16874326.html</guid>
   <pubDate>Tue, 12 May 2020 21:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
  <item>
   <title>Form  4          AKORN INC                 For: May 09  Filed by: Kafer Jonathan</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AKORN+INC+++++++++++++++++For%3A+May+09++Filed+by%3A+Kafer+Jonathan/16874324.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AKORN+INC+++++++++++++++++For%3A+May+09++Filed+by%3A+Kafer+Jonathan/16874324.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AKORN+INC+++++++++++++++++For%3A+May+09++Filed+by%3A+Kafer+Jonathan/16874324.html</guid>
   <pubDate>Tue, 12 May 2020 21:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AKRX</category>
   	  </item>
 </channel>
</rss>
